These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 11936221)

  • 1. Inhibitory effect of peroxisome proliferator-activated receptor gamma agonist on ochratoxin A-induced cytotoxicity and activation of transcription factors in cultured rat embryonic midbrain cells.
    Hong JT; Lee MK; Park KS; Jung KM; Lee RD; Jung HK; Park KL; Yang KJ; Chung YS
    J Toxicol Environ Health A; 2002 Mar; 65(5-6):407-18. PubMed ID: 11936221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
    Kim EJ; Park KS; Chung SY; Sheen YY; Moon DC; Song YS; Kim KS; Song S; Yun YP; Lee MK; Oh KW; Yoon DY; Hong JT
    J Pharmacol Exp Ther; 2003 Nov; 307(2):505-17. PubMed ID: 12966153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway.
    Park KS; Lee RD; Kang SK; Han SY; Park KL; Yang KH; Song YS; Park HJ; Lee YM; Yun YP; Oh KW; Kim DJ; Yun YW; Hwang SJ; Lee SE; Hong JT
    Exp Cell Res; 2004 Jul; 297(2):424-33. PubMed ID: 15212945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
    Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
    Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
    Zhang J; Fang NY; Gao PJ; Wu LY; Han WQ; Guo SJ; Shen WL; Zhu DL
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):72-7. PubMed ID: 18047631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism.
    Kang DS; Kwon CH; Park JY; Kim JH; Woo JS; Jung JS; Kim YK
    Toxicol Appl Pharmacol; 2006 Nov; 216(3):426-35. PubMed ID: 16890972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
    Haslmayer P; Thalhammer T; Jäger W; Aust S; Steiner G; Ensinger C; Obrist P
    Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ochratoxin A on cytotoxicity and cell differentiation in cultured rat embryonic cells.
    Hong JT; Park KL; Han SY; Park KS; Kim HS; Oh SD; Lee RD; Jang SJ
    J Toxicol Environ Health A; 2000 Dec; 61(7):609-21. PubMed ID: 11127415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of p38 mitogen-activated protein kinase and activator protein-1 during the promotion of neurite extension of PC-12 cells by 15-deoxy-delta12,14-prostaglandin J2.
    Jung KM; Park KS; Oh JH; Jung SY; Yang KH; Song YS; Son DJ; Park YH; Yun YP; Lee MK; Oh KW; Hong JT
    Mol Pharmacol; 2003 Mar; 63(3):607-16. PubMed ID: 12606768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 15-deoxy-delta12,14-prostaglandin J2 on cell proliferation and apoptosis in ECV304 endothelial cells.
    Dong YG; Chen DD; He JG; Guan YY
    Acta Pharmacol Sin; 2004 Jan; 25(1):47-53. PubMed ID: 14704122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin J2 and its metabolites promote neurite outgrowth induced by nerve growth factor in PC12 cells.
    Satoh T; Furuta K; Suzuki M; Watanabe Y
    Biochem Biophys Res Commun; 1999 Apr; 258(1):50-3. PubMed ID: 10222233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PGJ2 inhibition of LPS-induced inflammatory mediator expression from rat alveolar macrophages.
    Porter DW; Wolfarth M; Young SH; Rao MK; Meighan T; Barger M; Andrew ME; Huffman LJ
    J Toxicol Environ Health A; 2007 Dec; 70(23):1967-76. PubMed ID: 17966068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.
    Berry EB; Keelan JA; Helliwell RJ; Gilmour RS; Mitchell MD
    Mol Pharmacol; 2005 Jul; 68(1):169-78. PubMed ID: 15821150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
    Ward JE; Gould H; Harris T; Bonacci JV; Stewart AG
    Br J Pharmacol; 2004 Feb; 141(3):517-25. PubMed ID: 14718259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
    Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of peroxisome proliferator-activated receptor-gamma inhibits differentiation of preosteoblasts.
    Khan E; Abu-Amer Y
    J Lab Clin Med; 2003 Jul; 142(1):29-34. PubMed ID: 12878983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2.
    Butler R; Mitchell SH; Tindall DJ; Young CY
    Cell Growth Differ; 2000 Jan; 11(1):49-61. PubMed ID: 10672903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Chen ZY; Tseng CC
    Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.